Cresco Labs Inc. (CRLBF)
OTCMKTS · Delayed Price · Currency is USD
1.350
-0.005 (-0.37%)
Oct 14, 2025, 3:54 PM EDT
Cresco Labs Market Cap
Cresco Labs has a market cap or net worth of $471.57 million as of October 14, 2025. Its market cap has decreased by -17.94% in one year.
Market Cap
471.57M
Enterprise Value
862.01M
Revenue
677.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.35
Market Cap Chart
Since December 3, 2018, Cresco Labs's market cap has decreased from 627.84M to 471.57M, a decrease of -24.89%. That is a compound annual growth rate of -4.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 477.52M | 49.22% |
| Dec 31, 2024 | 320.01M | -30.65% |
| Dec 29, 2023 | 461.48M | -15.53% |
| Dec 30, 2022 | 546.30M | -71.66% |
| Dec 31, 2021 | 1.93B | -17.69% |
| Dec 31, 2020 | 2.34B | 148.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 694.90M |
| Elite Pharmaceuticals | 673.15M |
| Veradigm | 517.28M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 356.04M |
| CytoDyn | 334.34M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 259.79M |